Digital Life Coaching for Myeloma Patients Undergoing Transplantation
Completed · Not applicable
Conditions studied: Multiple Myeloma
In brief
This is the first study of digital life coaching (DLC) to engage patients during the peri-HCT period that is punctuated by intensive life changes. DLC may circumvent these limitations by combining the integrative cross-dimensional nature of life coaching with the advantages of mobile health technology. The purpose of this study is to evaluate whether ongoing participant engagement with a DLC platform is feasible for multiple myeloma (MM) patients actively undergoing hematopoietic stem cell transplantation (HCT).
Key facts
- Study ID
- NCT04432818
- Run by
- University of California, San Francisco
- People needed
- 17
- Starts
- 2020-05-20
- Expected to finish
- 2021-02-25
- Last updated by the study team
- 2021-06-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Confirmed diagnosis of one of the following (all referred to as MM in this protocol):
- Multiple myeloma (ICD-10 code: C90.0)
- Extramedullary plasmacytoma (ICD-10 code: C90.2)
- Planned receipt of autologous HCT at our institution
- Patients undergoing outpatient HCT will be eligible
- Patients who received chemomobilization will be eligible
- Age ≥ 18, as life coaches employed by the DLC vendor are not currently trained to work with pediatric patients
You may not qualify if…
- Prior autologous HCT for any indication
- Physician-assessed lack of sufficient English proficiency
- Lack of ownership of a personal smartphone
- Any serious and/or unstable pre-existing medical, psychiatric, or other condition that could interfere with participant's safety, provision of informed consent, or compliance with study procedures
Where it is running
- University of California, San Francisco — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.